Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program

Abstract

Erica Turse,1 Majd Aboona,2 Ericka Charley,1 Arnold Forlemu,1 Tessa Bowie,3 Bikash Bhattarai,3 Keng-Yu Chuang,4 Abdul Nadir2,4 1Department of Medicine, Creighton University School of Medicine Program, Phoenix, AZ, USA; 2Department of Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA; 3Department of Research, Valleywise Health Medical Center, Phoenix, AZ, USA; 4Department of Medicine, Valleywise Health Medical Center, Phoenix, AZ, USACorrespondence: Majd Aboona, Email [email protected]: With the rising incidence of hepatocellular carcinoma (HCC), ongoing efforts should be focused on providing equitable and state-of-the-art care to patients.Purpose: The aim of this study was to determine the survival of patients with HCC seen at a high-proportion Safety Net Hospital (h-SNH), where loco-regional therapy and hepatology services are available and liver transplantation (LT) is referred to outside facilities.Patients and Methods: A retrospective cohort study was conducted on all patients with HCC seen at Valley Wise Health Center (VWHC) over a ten-year period. Clinical variables, treatment modalities, survival duration, hospice, and LT referrals of 161 patients were collected from the medical records. Survival analysis was used to determine the relationship of clinically relevant variables and survival among patients with HCC. A Log rank test was used to compare univariate variables. A Cox regression analysis was used to compare and control for multiple variables.Results: Of the 161 patients included in the study, 33% were uninsured. The median age was 59 (21 to > 89) years with 47% Hispanic, 31% Caucasian, 15% African American and 7% other races included for the analysis. The median survival for the cohort was 20.1 months. In the multivariate model, insurance status, final MELD, tumor within the Milan criteria and having received treatment for HCC were associated with survival. Surveillance for HCC was associated with HCC in the univariate analysis, but not in the multivariable model. Thirty percent of patients were referred for LT and 1.25% of the entire cohort received it.Conclusion: Despite the availability of treatment modalities available for HCC at VWHC and the option of liver transplantation for appropriate candidates at outside centers, OS was less than reported from programs with on-site liver transplant programs. Reasons for lower survival in centers without liver transplant programs should be further studied.Keywords: liver cancer, cirrhosis, health disparities, health outcomes

Keywords

• liver cancer
• cirrhosis
• health disparities
• health outcomes